
Glaukos Investor Relations Material
Latest events

Q4 2024
Glaukos
Access the full event backlog
Slides, Transcripts, and Reports from 12,000+ public companies
Latest reports from Glaukos Corporation
Access all reports
Glaukos Corporation is a clinical-stage medical device company focused on the development and commercialization of breakthrough products and procedures designed to transform the treatment of glaucoma, corneal disorders and retinal diseases. Glaukos is an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment and management of glaucoma, corneal disorders and retinal diseases.
Key slides for Glaukos Corporation


43rd Annual J.P. Morgan Healthcare Conference 2025
Glaukos Corporation


43rd Annual J.P. Morgan Healthcare Conference 2025
Glaukos Corporation
Latest articles
)
James Quincey: Coca-Cola Chairman and CEO
James Quincey has dedicated nearly three decades to The Coca-Cola Company, rising through the ranks to become CEO and Chairman of the company.
11 Mar 2025
)
PepsiCo: From Pepsi and Gatorade to Doritos and Lay's
PepsiCo has grown from a soda company into a global leader in food and beverages, with a portfolio of over 200 brands, including Pepsi, Lay's, and Gatorade.
11 Mar 2025
)
Bob Iger: Disney's Visionary CEO
Bob Iger is a legend in the entertainment industry, known for his visionary leadership and as one of the most influential CEOs in Disney's history.
10 Mar 2025
Ticker symbol
GKOS
Country
🇺🇸 United States